$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Phytomedicine in Joint Disorders 원문보기

Nutrients, v.9 no.1, 2017년, pp.70 -   

Dragos, Dorin (Medical Semiology Department, Faculty of General Medicine, “Carol Davila” University of Medicine and Pharmacy, B-dul “Eroilor Sanitari” nr. 8, Sector 6, 76241 Bucharest, Romania) ,  Gilca, Marilena (dordrag@drdorindragos.ro) ,  Gaman, Laura (Biochemistry Department, Faculty of General Medicine, “Carol Davila” University of Medicine and Pharmacy, B-dul “Eroilor Sanitari” nr. 8, Sector 6, 76241 Bucharest, Romania) ,  Vlad, Adelina (marilenagilca@gmail.com (M.G.)) ,  Iosif, Liviu (glauraelena@gmail.com (L.G.)) ,  Stoian, Irina (Biochemistry Department, Faculty of General Medicine, “Carol Davila” University of Medicine and Pharmacy, B-dul “Eroilor Sanitari” nr. 8, Sector 6, 76241 Bucharest, Romania) ,  Lupescu, Olivera (marilenagilca@gmail.com (M.G.))

Abstract AI-Helper 아이콘AI-Helper

Chronic joint inflammatory disorders such as osteoarthritis and rheumatoid arthritis have in common an upsurge of inflammation, and oxidative stress, resulting in progressive histological alterations and disabling symptoms. Currently used conventional medication (ranging from pain-killers to biologi...

주제어

참고문헌 (137)

  1. 1. Hsu D.-Z. Chu P.-Y. Jou I.-M. Daily sesame oil supplement attenuates joint pain by inhibiting muscular oxidative stress in osteoarthritis rat model J. Nutr. Biochem. 2016 29 36 40 10.1016/j.jnutbio.2015.10.007 26895663 

  2. 2. Park S.-H. Kim S.-K. Shin I.-H. Kim H.-G. Choe J.-Y. Effects of AIF on Knee Osteoarthritis Patients: Double-blind, Randomized Placebo-controlled Study Korean J. Physiol. Pharmacol. 2009 13 33 37 10.4196/kjpp.2009.13.1.33 19885024 

  3. 3. Peat G. McCarney R. Croft P. Knee pain and osteoarthritis in older adults: A review of community burden and current use of primary health care Ann. Rheum. Dis. 2001 60 91 97 10.1136/ard.60.2.91 11156538 

  4. 4. McWilliams D.F. Leeb B.F. Muthuri S.G. Doherty M. Zhang W. Occupational risk factors for osteoarthritis of the knee: A meta-analysis Osteoarthr. Cartil. 2011 19 829 839 10.1016/j.joca.2011.02.016 21382500 

  5. 5. Smith R.L. Carter D.R. Schurman D.J. Pressure and shear differentially alter human articular chondrocyte metabolism: A review Clin. Orthop. Relat. Res. 2004 427 S89 S95 

  6. 6. Murphy N.J. Eyles J.P. Hunter D.J. Hip Osteoarthritis: Etiopathogenesis and Implications for Management Adv. Ther. 2016 33 1921 1946 10.1007/s12325-016-0409-3 27671326 

  7. 7. Dougados M. Monitoring osteoarthritis progression and therapy Osteoarthr. Cartil. 2004 12 Suppl. A S55 S60 10.1016/j.joca.2003.09.009 14698644 

  8. 8. Lequesne M.G. Mery C. Samson M. Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation—Value in comparison with other assessment tests Scand. J. Rheumatol. Suppl. 1987 65 85 89 10.3109/03009748709102182 3479839 

  9. 9. Johnson M.J. Bland J.M. Davidson P.M. Newton P.J. Oxberry S.G. Abernethy A.P. Currow D.C. The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status Scale J. Pain Symptom Manag. 2014 47 652 658 10.1016/j.jpainsymman.2013.05.006 23910628 

  10. 10. Yang C.L.H. Or T.C.T. Ho M.H.K. Lau A.S.Y. Scientific Basis of Botanical Medicine as Alternative Remedies for Rheumatoid Arthritis Clin. Rev. Allergy Immunol. 2013 44 284 300 10.1007/s12016-012-8329-8 22700248 

  11. 11. Smolen J.S. Landewe R. Breedveld F.C. Buch M. Burmester G. Dougados M. Emery P. Gaujoux-Viala C. Gossec L. Nam J. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update Ann. Rheum. Dis. 2014 73 492 509 10.1136/annrheumdis-2013-204573 24161836 

  12. 12. Hochberg M.C. Altman R.D. April K.T. Benkhalti M. Guyatt G. McGowan J. Towheed T. Welch V. Wells G. Tugwell P. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee Arthritis Care Res. 2012 64 465 474 10.1002/acr.21596 

  13. 13. Hyrich K.L. Watson K.D. Silman A.J. Symmons D.P.M. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register Rheumatology 2006 45 1558 1565 10.1093/rheumatology/kel149 16705046 

  14. 14. Soliman M.M. Hyrich K.L. Lunt M. Watson K.D. Symmons D.P.M. Ashcroft D.M. Effectiveness of rituximab in patients with rheumatoid arthritis: Observational study from the British Society for Rheumatology Biologics Register J. Rheumatol. 2012 39 240 246 10.3899/jrheum.110610 22174201 

  15. 15. Cavalli G. Dinarello C.A. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies Rheumatology 2015 54 2134 2144 10.1093/rheumatology/kev269 26209330 

  16. 16. Nishina N. Kaneko Y. Kameda H. Kuwana M. Takeuchi T. Reduction of plasma IL-6 but not TNF-alpha by methotrexate in patients with early rheumatoid arthritis: A potential biomarker for radiographic progression Clin. Rheumatol. 2013 32 1661 1666 10.1007/s10067-013-2309-0 23754245 

  17. 17. Abdel-Tawab M. Werz O. Schubert-Zsilavecz M. Boswellia serrata : An overall assessment of in vitro, preclinical, pharmacokinetic and clinical data Clin. Pharmacokinet. 2011 50 349 369 10.2165/11586800-000000000-00000 21553931 

  18. 18. McAlindon T.E. Bannuru R.R. Sullivan M.C. Arden N.K. Berenbaum F. Bierma-Zeinstra S.M. Hawker G.A. Henrotin Y. Hunter D.J. Kawaguchi H. OARSI guidelines for the non-surgical management of knee osteoarthritis Osteoarthr. Cartil. 2014 22 363 388 10.1016/j.joca.2014.01.003 24462672 

  19. 19. Matucci A. Cammelli D. Cantini F. Goletti D. Marino V. Milano G.M. Scarpa R. Tocci G. Maggi E. Vultaggio A. Influence of anti-TNF immunogenicity on safety in rheumatic disease: A narrative review Expert Opin. Drug Saf. 2016 15 3 10 10.1080/14740338.2016.1221398 27924646 

  20. 20. Cabral V.P. Andrade C.A. Passos S.R. Martins M.F. Hökerberg Y.H. Severe infection in patients with rheumatoid arthritis taking anakinra, rituximab, or abatacept: A systematic review of observational studies Rev. Bras. Reumatol. 2016 56 543 550 10.1016/j.rbr.2016.07.008 27751667 

  21. 21. Mameli A. Barcellona D. Marongiu F. Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors Am. J. Ther. 2017 24 e106 e107 10.1097/MJT.0000000000000486 27574942 

  22. 22. Umar S. Umar K. Sarwar A.H.M.G. Khan A. Ahmad N. Ahmad S. Katiyar C.K. Husain S.A. Khan H.A. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis Phytomedicine 2014 21 847 856 10.1016/j.phymed.2014.02.001 24667331 

  23. 23. Akhtar N. Miller M.J. Haqqi T.M. Effect of a Herbal-Leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytes BMC Complement. Altern. Med. 2011 11 66 10.1186/1472-6882-11-66 21854562 

  24. 24. Sharma S. Arif M. Nirala R.K. Gupta R. Thakur S.C. Cumulative therapeutic effects of phytochemicals in Arnica montana flower extract alleviated collagen-induced arthritis: Inhibition of both pro-inflammatory mediators and oxidative stress J. Sci. Food Agric. 2016 96 1500 1510 10.1002/jsfa.7252 25966322 

  25. 25. Álvarez-Hernández E. César Casasola-Vargas J. Lino-Pérez L. Burgos-Vargas R. Vázquez-Mellado J. Frecuencia de uso de medicinas complementarias y alternativas en sujetos que acuden por primera vez al servicio de reumatología. Análisis de 800 casos Reumatol. Clín. 2006 2 183 189 10.1016/S1699-258X(06)73044-3 21794326 

  26. 26. Knuesel O. Weber M. Suter A. Arnica montana gel in osteoarthritis of the knee: An open, multicenter clinical trial Adv. Ther. 2002 19 209 218 10.1007/BF02850361 12539881 

  27. 27. Widrig R. Suter A. Saller R. Melzer J. Choosing between NSAID and Arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study Rheumatol. Int. 2007 27 585 591 10.1007/s00296-007-0304-y 17318618 

  28. 28. Ross S.M. Osteoarthritis Holist. Nurs. Pract. 2008 22 237 239 10.1097/01.HNP.0000326007.03429.3e 18607237 

  29. 29. Cameron M. Chrubasik S. Topical herbal therapies for treating osteoarthritis CDSR 2013 2013 CD010538 10.1002/14651858.CD010538 

  30. 30. Ammon H.P.T. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases Wien. Med. Wochenschr. 2002 152 373 378 (In German) 10.1046/j.1563-258X.2002.02056.x 12244881 

  31. 31. Sengupta K. Krishnaraju A.V. Vishal A.A. Mishra A. Trimurtulu G. Sarma K.V.S. Raychaudhuri S.K. Raychaudhuri S.P. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: A double blind, randomized, placebo controlled clinical study Int. J. Med. Sci. 2010 7 366 377 10.7150/ijms.7.366 21060724 

  32. 32. Blain E.J. Ali A.Y. Duance V.C. Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilage Phyther. Res. 2009 24 905 912 10.1002/ptr.3055 19943332 

  33. 33. Sumantran V.N. Joshi A.K. Boddul S. Koppikar S.J. Warude D. Patwardhan B. Chopra A. Chandwaskar R. Wagh U.V. Antiarthritic Activity of a Standardized, Multiherbal, Ayurvedic Formulation containing Boswellia serrata : In Vitro Studies on Knee Cartilage from Osteoarthritis Patients Phyther. Res. 2011 25 1375 1380 10.1002/ptr.3365 25363757 

  34. 34. Dey D. Chaskar S. Athavale N. Chitre D. Inhibition of LPS-Induced TNF-α and NO Production in Mouse Macrophage and Inflammatory Response in Rat Animal Models by a Novel Ayurvedic Formulation, BV-9238 Phyther. Res. 2014 28 1479 1485 10.1002/ptr.5151 

  35. 35. Cameron M. Chrubasik S. Oral herbal therapies for treating osteoarthritis CDSR 2014 2014 CD002947 10.1002/14651858.CD002947.pub2 

  36. 36. Vishal A.A. Mishra A. Raychaudhuri S.P. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee Int. J. Med. Sci. 2011 8 615 622 10.7150/ijms.8.615 22022214 

  37. 37. Belcaro G. Dugall M. Luzzi R. Ledda A. Pellegrini L. Cesarone M.R. Hosoi M. Errichi M. Francis S. Cornelli U. FlexiQule ( Boswellia extract) in the supplementary management of osteoarthritis: A supplement registry Minerva Med. 2014 105 9 16 

  38. 38. Belcaro G. Feragalli B. Cornelli U. Dugall M. Hand “stress” arthritis in young subjects: Effects of Flexiqule (pharma-standard Boswellia extract). A preliminary case report Minerva Gastroenterol. Dietol. 2015 in press 

  39. 39. Kizhakkedath R. Clinical evaluation of a formulation containing Curcuma longa and Boswellia serrata extracts in the management of knee osteoarthritis Mol. Med. Rep. 2013 8 1542 1548 10.3892/mmr.2013.1661 24002213 

  40. 40. Sander O. Herborn G. Rau R. Is H15 (resin extract of Boswellia serrata , “incense”) a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study Z. Rheumatol. 1998 57 11 16 10.1007/s003930050051 9566100 

  41. 41. Wang H. Zhang C. Wu Y. Ai Y. Lee D.Y.-W. Dai R. Comparative pharmacokinetic study of two boswellic acids in normal and arthritic rat plasma after oral administration of Boswellia serrata extract or Huo Luo Xiao Ling Dan by LC-MS Biomed. Chromatogr. 2014 28 1402 1408 10.1002/bmc.3182 24806456 

  42. 42. Hamidpour R. Hamidpour S. Hamidpour M. Shahlari M. Frankincense (Rǔ Xiāng; Boswellia Species): From the Selection of Traditional Applications to the Novel Phytotherapy for the Prevention and Treatment of Serious Diseases J. Tradit. Complement. Med. 2013 3 221 226 10.4103/2225-4110.119723 24716181 

  43. 43. Sharma M.L. Bani S. Singh G.B. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis Int. J. Immunopharmacol. 1989 11 647 652 10.1016/0192-0561(89)90150-1 2807636 

  44. 44. Singh S. Khajuria A. Taneja S.C. Johri R.K. Singh J. Qazi G.N. Boswellic acids: A leukotriene inhibitor also effective through topical application in inflammatory disorders Phytomedicine 2008 15 400 407 10.1016/j.phymed.2007.11.019 18222672 

  45. 45. Ammon H.P.T. Modulation of the immune system by Boswellia serrata extracts and boswellic acids Phytomedicine 2010 17 862 867 10.1016/j.phymed.2010.03.003 20696559 

  46. 46. Khajuria A. Gupta A. Suden P. Singh S. Malik F. Singh J. Gupta B.D. Suri K.A. Srinivas V.K. Ella K. Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata Phyther. Res. 2008 22 340 348 10.1002/ptr.2320 18167047 

  47. 47. Sengupta K. Kolla J.N. Krishnaraju A.V. Yalamanchili N. Rao C.V. Golakoti T. Raychaudhuri S. Raychaudhuri S.P. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: A novel Boswellia serrata extract Mol. Cell. Biochem. 2011 354 189 197 10.1007/s11010-011-0818-1 21479939 

  48. 48. Sharma R. Dash B. Caraka Samhita 2006th ed. Chowkhamba Sanskrit Series Office Varanasi, India 2006 

  49. 49. Funk J.L. Frye J.B. Oyarzo J.N. Kuscuoglu N. Wilson J. McCaffrey G. Stafford G. Chen G. Lantz R.C. Jolad S.D. Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis Arthritis Rheum. 2006 54 3452 3464 10.1002/art.22180 17075840 

  50. 50. Taty Anna K. Elvy Suhana M.R. Das S. Faizah O. Hamzaini A.H. Anti-inflammatory effect of Curcuma longa (turmeric) on collagen-induced arthritis: An anatomico-radiological study Clin. Ter. 2011 162 201 207 21717043 

  51. 51. Kamarudin T.A. Othman F. Mohd Ramli E.S. Md Isa N. Das S. Protective effect of curcumin on experimentally induced arthritic rats: Detailed histopathological study of the joints and white blood cell count EXCLI J. 2012 11 226 236 27366139 

  52. 52. Chang H.-I. Su Y.-H. Lin Y.-J. Chen P.-J. Shi C.-S. Chen C.-N. Yeh C.-C. Evaluation of the protective effects of curcuminoid (curcumin and bisdemethoxycurcumin)-loaded liposomes against bone turnover in a cell-based model of osteoarthritis Drug Des. Dev. Ther. 2015 9 2285 2300 10.2147/DDDT.S78277 25945040 

  53. 53. Ramadan G. El-Menshawy O. Protective effects of ginger-turmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis Int. J. Rheum. Dis. 2013 16 219 229 10.1111/1756-185X.12054 23773648 

  54. 54. Kuptniratsaikul V. Dajpratham P. Taechaarpornkul W. Buntragulpoontawee M. Lukkanapichonchut P. Chootip C. Saengsuwan J. Tantayakom K. Laongpech S. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: A multicenter study Clin. Interv. Aging 2014 9 451 458 10.2147/CIA.S58535 24672232 

  55. 55. Daily J.W. Yang M. Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials J. Med. Food 2016 19 717 729 10.1089/jmf.2016.3705 27533649 

  56. 56. Ghosh S. Banerjee S. Sil P.C. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update Food Chem. Toxicol. 2015 83 111 124 10.1016/j.fct.2015.05.022 26066364 

  57. 57. Nonose N. Pereira J.A. Machado P.R.M. Rodrigues M.R. Sato D.T. Martinez C.A.R. Oral administration of curcumin ( Curcuma longa ) can attenuate the neutrophil inflammatory response in zymosan-induced arthritis in rats Acta Cir. Bras. 2014 29 727 734 10.1590/S0102-86502014001800006 25424293 

  58. 58. Panahi Y. Alishiri G.H. Parvin S. Sahebkar A. Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial J. Diet. Suppl. 2016 13 209 220 10.3109/19390211.2015.1008611 25688638 

  59. 59. Chen J.-J. Dai L. Zhao L.-X. Zhu X. Cao S. Gao Y.-J. Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis Sci. Rep. 2015 5 10278 10.1038/srep10278 25988362 

  60. 60. Zou S. Wang C. Cui Z. Guo P. Meng Q. Shi X. Gao Y. Yang G. Han Z. β-Elemene induces apoptosis of human rheumatoid arthritis fibroblast-like synoviocytes via reactive oxygen species-dependent activation of p38 mitogen-activated protein kinase Pharmacol. Rep. 2016 68 7 11 10.1016/j.pharep.2015.06.004 26721344 

  61. 61. Gründemann C. Lengen K. Sauer B. Garcia-Käufer M. Zehl M. Huber R. Equisetum arvense (common horsetail) modulates the function of inflammatory immunocompetent cells BMC Complement. Altern. Med. 2014 14 283 10.1186/1472-6882-14-283 25088216 

  62. 62. Farinon M. Lora P.S. Francescato L.N. Bassani V.L. Henriques A.T. Xavier R.M. de Oliveira P.G. Effect of Aqueous Extract of Giant Horsetail ( Equisetum giganteum L.) in Antigen-Induced Arthritis Open Rheumatol. J. 2013 7 129 133 10.2174/1874312901307010129 24494034 

  63. 63. Jiang X. Qu Q. Li M. Miao S. Li X. Cai W. Horsetail mixture on rheumatoid arthritis and its regulation on TNF-α and IL-10 Pak. J. Pharm. Sci. 2014 27 2019 2023 25410066 

  64. 64. Zgrajka W. Turska M. Rajtar G. Majdan M. Parada-Turska J. Kynurenic acid content in anti-rheumatic herbs Ann. Agric. Environ. Med. 2013 20 800 802 24364456 

  65. 65. Varga G. Erces D. Fazekas B. Fulop M. Kovacs T. Kaszaki J. Fulop F. Vecsei L. Boros M. N -Methyl- d -aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat Neurogastroenterol. Motil. 2010 22 217 225 10.1111/j.1365-2982.2009.01390.x 19735360 

  66. 66. Parada-Turska J. Rzeski W. Zgrajka W. Majdan M. Kandefer-Szerszen M. Turski W. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro Rheumatol. Int. 2006 26 422 426 10.1007/s00296-005-0057-4 16220290 

  67. 67. Parada-Turska J. Zgrajka W. Majdan M. Kynurenic acid in synovial fluid and serum of patients with rheumatoid arthritis, spondyloarthropathy, and osteoarthritis J. Rheumatol. 2013 40 903 909 10.3899/jrheum.121035 23588943 

  68. 68. Blumenthal M. Busse W.R. The Complete German Commission E Monographs American Botanical Council Austin, TX, USA 1998 

  69. 69. Fiebich B. Heinrich M. Hiller K. Kammerer N. Inhibition of TNF-α synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69 Phytomedicine 2001 8 28 30 10.1078/0944-7113-00002 11292236 

  70. 70. Lanhers M. Fleurentin J. Mortier F. Al E. Antiinflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens Planta Med. 1992 58 117 123 10.1055/s-2006-961411 1529021 

  71. 71. Akhtar N. Haqqi T.M. Current nutraceuticals in the management of osteoarthritis: A review Ther. Adv. Musculoskelet. Dis. 2012 4 181 207 10.1177/1759720X11436238 22850529 

  72. 72. Wegener T. Lupke N. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil’s claw ( Harpagophytum procumbens DC.) Phytother. Res. 2003 17 1165 1172 10.1002/ptr.1322 14669250 

  73. 73. Chantre P. Cappelaere A. Leblan D. Al E. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis Phytomedicine 2000 7 177 183 10.1016/S0944-7113(00)80001-X 11185727 

  74. 74. Chrubasik S. Thanner J. Kunzel O. Al E. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin in patients with pain in the lower back, knee, or hip Phytomedicine 2002 9 181 194 10.1078/0944-7113-00140 12046857 

  75. 75. Harpagophytum procumbens (devil’s claw). Monograph Altern. Med. Rev. 2008 13 248 252 18950251 

  76. 76. Huang T.H.-W. Tran V.H. Duke R.K. Tan S. Chrubasik S. Roufogalis B.D. Duke C.C. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-κB activation J. Ethnopharmacol. 2006 104 149 155 10.1016/j.jep.2005.08.055 16203115 

  77. 77. Kaszkin M. Beck K. Koch E. Al E. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects Phytomedicine 2004 11 585 595 10.1016/j.phymed.2004.02.003 15636171 

  78. 78. Liu Z. Liu L. Essentials of Chinese Medicine Liu Z. Liu L. Springer London, UK 2009 

  79. 79. Chang S.-H. Choi Y. Park J.-A. Jung D.-S. Shin J. Yang J.-H. Ko S.-Y. Kim S.-W. Kim J.-K. Anti-inflammatory effects of BT-201, an n -butanol extract of Panax notoginseng , observed in vitro and in a collagen-induced arthritis model Clin. Nutr. 2007 26 785 791 10.1016/j.clnu.2007.07.008 17933436 

  80. 80. Chang S.-H. Sung H.-C. Choi Y. Ko S.-Y. Lee B.-E. Baek D.-H. Kim S.-W. Kim J.-K. Suppressive effect of AIF, a water extract from three herbs, on collagen-induced arthritis in mice Int. Immunopharmacol. 2005 5 1365 1372 10.1016/j.intimp.2005.02.019 15953563 

  81. 81. Zhang L. Li Z. Sun J. Ma J. Zhang S. Liu J. Zhu J. Effect of Panax Notoginseng Saponins on autograft tendon healing in bone tunnel: Interface histological characteristics Zhongguo Gu Shang 2011 24 132 136 21438325 

  82. 82. Zhang J. Wang J. Wang H. Clinical study on effect of total Panax notoginseng saponins on immune related inner environment imbalance in rheumatoid arthritis patients Zhongguo Zhong Xi Yi Jie He Za Zhi/Chin. J. Integr. Tradit. West. Med. 2007 27 589 592 

  83. 83. Appelboom T. Arthropathy in art and the history of pain management—Through the centuries to cyclooxygenase-2 inhibitors Rheumatology 2002 41 Suppl. 1 28 34 10.1093/rheumatology/41.suppl_1.28 12173278 

  84. 84. Vlachojannis J.E. Cameron M. Chrubasik S. A systematic review on the effectiveness of willow bark for musculoskeletal pain Phyther. Res. 2009 23 897 900 10.1002/ptr.2747 19140170 

  85. 85. Mackowiak P.A. Brief History of Antipyretic Therapy Clin. Infect. Dis. 2000 31 S154 S156 10.1086/317510 11113017 

  86. 86. Vane J.R. The fight against rheumatism: From willow bark to COX-1 sparing drugs J. Physiol. Pharmacol. 2000 51 573 586 11192932 

  87. 87. Bonaterra G.A. Heinrich E.U. Kelber O. Weiser D. Metz J. Kinscherf R. Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv ® ) in LPS-activated human monocytes and differentiated macrophages Phytomedicine 2010 17 1106 1113 10.1016/j.phymed.2010.03.022 20570123 

  88. 88. Khayyal M. El-Ghazaly M. Abdallah D. Okpanyi S. Kelber O. Weiser D. Mechanisms Involved in the Anti-inflammatory Effect of a Standardized Willow Bark Extract Arzneimittelforschung 2011 55 677 687 10.1055/s-0031-1296917 16366042 

  89. 89. Sharma S. Sahu D. Das H.R. Sharma D. Amelioration of collagen-induced arthritis by Salix nigra bark extract via suppression of pro-inflammatory cytokines and oxidative stress Food Chem. Toxicol. 2011 49 3395 3406 10.1016/j.fct.2011.08.013 21983485 

  90. 90. Schmid B. Lüdtke R. Selbmann H.K. Kötter I. Tschirdewahn B. Schaffner W. Heide L. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: Randomized placebo-controlled, double blind clinical trial Phytother. Res. 2001 15 344 350 10.1002/ptr.981 11406860 

  91. 91. Biegert C. Wagner I. Lüdtke R. Kötter I. Lohmüller C. Günaydin I. Taxis K. Heide L. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: Results of 2 randomized double-blind controlled trials J. Rheumatol. 2004 31 2121 2130 15517622 

  92. 92. Beer A.-M. Wegener T. Willow bark extract ( Salicis cortex ) for gonarthrosis and coxarthrosis—Results of a cohort study with a control group Phytomedicine 2008 15 907 913 10.1016/j.phymed.2008.07.010 18815018 

  93. 93. Uehleke B. Müller J. Stange R. Kelber O. Melzer J. Willow bark extract STW 33-I in the long-term treatment of outpatients with rheumatic pain mainly osteoarthritis or back pain Phytomedicine 2013 20 980 984 10.1016/j.phymed.2013.03.023 23731658 

  94. 94. Nahrstedt A. Schmidt M. Jäggi R. Metz J. Khayyal M.T. Willow bark extract: The contribution of polyphenols to the overall effect Wien. Med. Wochenschr. 2007 157 348 351 10.1007/s10354-007-0437-3 17704985 

  95. 95. Drummond E.M. Harbourne N. Marete E. Martyn D. Jacquier J. O’Riordan D. Gibney E.R. Inhibition of Proinflammatory Biomarkers in THP1 Macrophages by Polyphenols Derived From Chamomile, Meadowsweet and Willow bark Phyther. Res. 2013 27 588 594 10.1002/ptr.4753 22711544 

  96. 96. Shara M. Stohs S.J. Efficacy and Safety of White Willow Bark ( Salix alba ) Extracts Phyther. Res. 2015 29 1112 1116 10.1002/ptr.5377 25997859 

  97. 97. Hsu D.-Z. Chen S.-J. Chu P.-Y. Liu M.-Y. Therapeutic effects of sesame oil on monosodium urate crystal-induced acute inflammatory response in rats Springerplus 2013 2 659 10.1186/2193-1801-2-659 24353977 

  98. 98. Sotnikova R. Ponist S. Navarova J. Mihalova D. Tomekova V. Strosova M. Bauerova K. Effects of sesame oil in the model of adjuvant arthritis Neuro Endocrinol. Lett. 2009 30 Suppl. 1 22 24 

  99. 99. Yadav N.V. Sadashivaiah Ramaiyan B. Acharya P. Belur L. Talahalli R.R. Sesame Oil and Rice Bran Oil Ameliorates Adjuvant-Induced Arthritis in Rats: Distinguishing the Role of Minor Components and Fatty Acids Lipids 2016 51 1385 1395 10.1007/s11745-016-4203-4 27747452 

  100. 100. Eftekhar Sadat B. Khadem Haghighian M. Alipoor B. Malek Mahdavi A. Asghari Jafarabadi M. Moghaddam A. Effects of sesame seed supplementation on clinical signs and symptoms in patients with knee osteoarthritis Int. J. Rheum. Dis. 2013 16 578 582 10.1111/1756-185X.12133 24164846 

  101. 101. Khadem Haghighian M. Alipoor B. Malek Mahdavi A. Eftekhar Sadat B. Asghari Jafarabadi M. Moghaddam A. Effects of sesame seed supplementation on inflammatory factors and oxidative stress biomarkers in patients with knee osteoarthritis Acta Med. Iran. 2015 53 207 213 25871017 

  102. 102. Yashaswini P.S. Rao A.G.A. Singh S.A. Inhibition of lipoxygenase by sesamol corroborates its potential anti-inflammatory activity Int. J. Biol. Macromol. 2017 94 781 787 10.1016/j.ijbiomac.2016.06.048 27316769 

  103. 103. Hemshekhar M. Thushara R.M. Jnaneshwari S. Devaraja S. Kemparaju K. Girish K.S. Attenuation of adjuvant-induced arthritis by dietary sesamol via modulation of inflammatory mediators, extracellular matrix degrading enzymes and antioxidant status Eur. J. Nutr. 2013 52 1787 1799 10.1007/s00394-012-0482-6 23269651 

  104. 104. Khansai M. Boonmaleerat K. Pothacharoen P. Phitak T. Kongtawelert P. Ex vivo model exhibits protective effects of sesamin against destruction of cartilage induced with a combination of tumor necrosis factor-alpha and oncostatin M BMC Complement. Altern. Med. 2016 16 10.1186/s12906-016-1183-0 27400672 

  105. 105. Cavero R.Y. Calvo M.I. Medicinal plants used for musculoskeletal disorders in Navarra and their pharmacological validation J. Ethnopharmacol. 2015 168 255 259 10.1016/j.jep.2015.03.078 25862964 

  106. 106. Di Lorenzo C. Dell’Agli M. Badea M. Dima L. Colombo E. Sangiovanni E. Restani P. Bosisio E. Plant food supplements with anti-inflammatory properties: A systematic review (II) Crit. Rev. Food Sci. Nutr. 2013 53 507 516 10.1080/10408398.2012.691916 23391017 

  107. 107. Gilca M. Gaman L. Lixandru D. Stoian I. Estimating the yin-yang nature of Western herbs: A potential tool based on antioxidation-oxidation theory Afr. J. Tradit. Complement. Altern. Med. 2014 11 210 216 10.4314/ajtcam.v11i3.29 25371584 

  108. 108. Hiermann A. Writzel M. Antiphlogistic glycopeptide from the roots of Symphytum officinale Pharm. Pharmacol. Lett. 1998 8 154 157 

  109. 109. Mascolo N. Autore G. Capasso F. Menghini A. Fasulo M.P. Biological screening of Italian medicinal plants for anti-inflammatory activity Phyther. Res. 1987 1 28 31 10.1002/ptr.2650010107 

  110. 110. Laslett L.L. Quinn S.J. Darian-Smith E. Kwok M. Fedorova T. Körner H. Steels E. March L. Jones G. Treatment with 4Jointz reduces knee pain over 12 weeks of treatment in patients with clinical knee osteoarthritis: A randomised controlled trial Osteoarthr. Cartil. 2012 20 1209 1216 10.1016/j.joca.2012.07.019 22863612 

  111. 111. Grube B. Grünwald J. Krug L. Staiger C. Efficacy of a comfrey root ( Symphyti offic. radix ) extract ointment in the treatment of patients with painful osteoarthritis of the knee: Results of a double-blind, randomised, bicenter, placebo-controlled trial Phytomedicine 2007 14 2 10 10.1016/j.phymed.2006.11.006 17169543 

  112. 112. Gracza L. Koch H. Loffler E. Biochemical-pharmacologic studies of medicinal plants. 1. Isolation of rosmarinic acid from Symphytum officinale L. and its anti-inflammatory activity in an in vitro model Arch. Pharm. 1985 318 1090 1095 10.1002/ardp.19853181207 

  113. 113. Gracza L. Prüfung der membranabdichtenden Wirkung eines Phytopharmakons und dessen Wirkstoffe Z. Phytother. 1987 8 78 81 

  114. 114. Huang S.-H. Lee C.-H. Wang H.-M. Chang Y.-W. Lin C.-Y. Chen C.-Y. Chen Y.-H. 6-Dehydrogingerdione restrains lipopolysaccharide-induced inflammatory responses in RAW 264.7 macrophages J. Agric. Food Chem. 2014 62 9171 9179 10.1021/jf501665v 25162585 

  115. 115. Van Breemen R.B. Tao Y. Li W. Cyclooxygenase-2 inhibitors in ginger ( Zingiber officinale ) Fitoterapia 2011 82 38 43 10.1016/j.fitote.2010.09.004 20837112 

  116. 116. Grzanna R. Lindmark L. Frondoza C.G. Ginger—An herbal medicinal product with broad anti-inflammatory actions J. Med. Food 2005 8 125 132 10.1089/jmf.2005.8.125 16117603 

  117. 117. Ueda H. Ippoushi K. Takeuchi A. Repeated oral administration of a squeezed ginger ( Zingiber officinale ) extract augmented the serum corticosterone level and had anti-inflammatory properties Biosci. Biotechnol. Biochem. 2010 74 2248 2252 10.1271/bbb.100456 21071834 

  118. 118. Naderi Z. Mozaffari-Khosravi H. Dehghan A. Nadjarzadeh A. Huseini H.F. Effect of ginger powder supplementation on nitric oxide and C-reactive protein in elderly knee osteoarthritis patients: A 12-week double-blind randomized placebo-controlled clinical trial J. Tradit. Complement. Med. 2016 6 199 203 10.1016/j.jtcme.2014.12.007 27419081 

  119. 119. Altman R.D. Marcussen K.C. Effects of a ginger extract on knee pain in patients with osteoarthritis Arthritis Rheum. 2001 44 2531 2538 10.1002/1529-0131(200111)44:11 3.0.CO;2-J 11710709 

  120. 120. Alipour Z. Asadizaker M. Fayazi S. Yegane N. Kochak M. Haghighi Zadeh M.H. The Effect of Ginger on Pain and Satisfaction of Patients with Knee Osteoarthritis Jundishapur J. Chronic Dis. Care 2016 6 e34798 10.17795/jjcdc-34798 

  121. 121. Haghighi M. Khalvat A. Toliat T. Jallaei S. Comparing the effects of ginger extract and ibuprofen in patients with osteoporosis Arch. Iran. Med. 2005 8 267 271 

  122. 122. Drozdov V.N. Kim V.A. Tkachenko E.V. Varvanina G.G. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip J. Altern. Complement. Med. 2012 18 583 588 10.1089/acm.2011.0202 22784345 

  123. 123. Bliddal H. Rosetzsky A. Schlichting P. Weidner M.S. Andersen L.A. Ibfelt H.H. Christensen K. Jensen O.N. Barslev J. A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis Osteoarthr. Cartil. 2000 8 9 12 10.1053/joca.1999.0264 10607493 

  124. 124. Lee H.Y. Park S.H. Lee M. Kim H.-J. Ryu S.Y. Kim N.D. Hwang B.Y. Hong J.T. Han S.-B. Kim Y. 1-Dehydro-[10]-gingerdione from ginger inhibits IKKβ activity for NF-κB activation and suppresses NF-κB-regulated expression of inflammatory genes Br. J. Pharmacol. 2012 167 128 140 10.1111/j.1476-5381.2012.01980.x 22489648 

  125. 125. Singh N. Bhalla M. de Jager P. Gilca M. An overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda Afr. J. Tradit. Complement. Altern. Med. 2011 8 208 213 10.4314/ajtcam.v8i5S.9 22754076 

  126. 126. Singh D. Aggarwal A. Maurya R. Naik S. Withania somnifera inhibits NF-κB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells Phytother. Res. 2007 21 905 913 10.1002/ptr.2180 17562568 

  127. 127. Ganesan K. Sehgal P.K. Mandal A.B. Sayeed S. Protective effect of Withania somnifera and Cardiospermum halicacabum extracts against collagenolytic degradation of collagen Appl. Biochem. Biotechnol. 2011 165 1075 1091 10.1007/s12010-011-9326-8 21789568 

  128. 128. Rasool M. Varalakshmi P. Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats Fundam. Clin. Pharmacol. 2007 21 157 164 10.1111/j.1472-8206.2006.00461.x 17391288 

  129. 129. Ramakanth G.S.H. Uday Kumar C. Kishan P.V. Usharani P. A randomized, double blind placebo controlled study of efficacy and tolerability of Withaina somnifera extracts in knee joint pain J. Ayurveda Integr. Med. 2016 7 151 157 10.1016/j.jaim.2016.05.003 27647541 

  130. 130. Sabina E.P. Chandal S. Rasool M.K. Inhibition of monosodium urate crystal-induced inflammation by withaferin A J. Pharm. Pharm. Sci. 2008 11 46 55 19183513 

  131. 131. Grover A. Shandilya A. Punetha A. Bisaria V.S. Sundar D. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera’s key metabolite withaferin A BMC Genom. 2010 11 Suppl. 4 S25 10.1186/1471-2164-11-S4-S25 21143809 

  132. 132. Heyninck K. Lahtela-Kakkonen M. van der Veken P. Haegeman G. Vanden Berghe W. Withaferin A inhibits NF-κB activation by targeting cysteine 179 in IKKβ Biochem. Pharmacol. 2014 91 501 509 10.1016/j.bcp.2014.08.004 25159986 

  133. 133. Bee T.A. Liew A. Hons P. Dietary Supplements Used in Osteoarthritis Proc. Singap. Healthc. 2010 19 237 247 10.1177/201010581001900310 

  134. 134. Posadzki P. Watson L. Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): An overview of systematic reviews Eur. J. Clin. Pharmacol. 2013 69 295 307 10.1007/s00228-012-1353-z 22843016 

  135. 135. Ernst E. Risks of herbal medicinal products Pharmacoepidemiol. Drug Saf. 2004 13 767 771 10.1002/pds.1014 15386721 

  136. 136. Posadzki P. Watson L. Ernst E. Herb-drug interactions: An overview of systematic reviews Br. J. Clin. Pharmacol. 2013 75 603 618 10.1111/j.1365-2125.2012.04350.x 22670731 

  137. 137. Bhattaram V.A. Graefe U. Kohlert C. Veit M. Derendorf H. Pharmacokinetics and bioavailability of herbal medicinal products Phytomedicine 2002 9 Suppl. 3 1 33 10.1078/1433-187X-00210 12222652 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로